Sabby Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-771
Closed -$6.1M 311
2016
Q3
$6.1M Buy
+771
New +$62.6K 0.23% 66
2016
Q2
Sell
-50
Closed -$459K 309
2016
Q1
$459K Sell
50
-864
-95% -$77.9K 0.02% 215
2015
Q4
$9.25M Sell
914
-4,059
-82% -$422K 0.51% 35
2015
Q3
$48.8M Buy
4,973
+2,038
+69% +$226K 2.01% 6
2015
Q2
$34.4M Buy
2,935
+1,103
+60% +$121K 1.25% 14
2015
Q1
$18M Sell
1,832
-10,353
-85% -$1.05M 0.75% 29
2014
Q4
$115K Sell
12,185
-1,618
-12% -$167K 3.63% 6
2014
Q3
$147K Buy
13,803
+4,147
+43% +$406K 5.64% 4
2014
Q2
$80.1M Sell
9,656
-1,510
-14% -$118K 3.43% 6
2014
Q1
$79.1M Buy
11,166
+4,358
+64% +$342K 4.44% 5
2013
Q4
$51.2M Sell
6,808
-1,698
-20% -$118K 3.26% 8
2013
Q3
$53.5M Buy
8,506
+976
+13% +$58.3K 3.47% 7
2013
Q2
$38.6M Buy
+7,530
New +$392K 2.57% 10

Other funds holding GILD

Sabby Management's GILD Position: Q4 2015 in Review

Sabby Management sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 45,140 shares — an estimated $4.7M sold.

Sabby Management first reported a position in GILD in Q2 2013 and held it in 6 quarters. The position peaked at $11M in Q1 2014. 1,627 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

  • Sabby Management reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
  • Sabby Management sold 45,140 Gilead Sciences shares in Q4 2015, an estimated $4.7M.
  • Sabby Management first reported a position in Gilead Sciences in Q2 2013 and held it in 6 quarters.
  • Sabby Management's Gilead Sciences position peaked at $11M in Q1 2014.
  • 1,627 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Sabby Management's 13F filing for Q4 2015, filed 16 Feb 2016.